NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
NovAccess Global Advisory on Annual Meeting of Shareholders
NovAccess Global Announces New License to Advance its Immunotherapy Platform
NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
NovAccess Global Announces $10.7 Million Financing
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
NovAccess Global to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
